Spis treści:
1. REPORT
2. INFORMATION ABOUT THE ENTITY
3. SIGNATURE OF PERSONS REPRESENTING THE COMPANY

Spis załączników:
  1. Krka Group estimated operating results for H1 2026.pdfKrka Group estimated opereting results for H1 2026

POLISH FINANCIAL SUPERVISION AUTHORITY

UNI - EN REPORT No 28 / 2026
Date of issue: 2026-07-09
Short name of the issuer
KRKA
Subject
Information regarding estimated operating results of the Krka Group for the first half of 2026
Official market - legal basis
Art. 17 ust. 1 MAR
Unofficial market - legal basis
Contents of the report:
Based on Article 17 of Regulation (EU) no. 596/2014 company Krka, d. d., Novo mesto releases information regarding estimated operating results of the Krka Group for the first half of 2026.

See attached document.


The notice will be published on the Company's website (www.krka.biz) from 9 July 2026 onwards, for a minimum 5 years.
Annexes
File Description
Krka Group estimated operating results for H1 2026.pdf
Krka Group estimated operating results for H1 2026.pdf		 Krka Group estimated opereting results for H1 2026

KRKA, TOVARNA ZDRAVIL D.D.
(fullname of the issuer)
KRKA Farmaceutyczny (far)
(short name of the issuer) (sector according to clasification
of the WSE in Warsow)
8501 Nove Mesto
(post code) (city)
Smarjeska 6
(street) (number)
+386 7 331 21 11 +386 7 332 15 37
(phone number) (fax)
(e-mail) (web site)
nie dotyczy
(NIP) (REGON)

SIGNATURE OF PERSONS REPRESENTING THE COMPANY
Date Name Position / Function Signature
2026-07-09 Jože Colarič President of the Management Board and CEO
20260709_132836_0351949289_Krka_Group_estimated_operating_results_for_H1_2026.pdf

Pobierz